Introduction. * Corresponding author. Tel: þ ; fax: þ address:
|
|
- Molly Daniels
- 6 years ago
- Views:
Transcription
1 European Heart Journal Supplements (2005) 7 (Supplement K), K36 K40 doi: /eurheartj/sui076 A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction Arnoud W.J. van t Hof 1 *, Henri van de Wetering 2, Nicolette Ernst 1, Frans Hollak 2, Frank de Pooter 3, Harry Suryapranata 1, Jan C.A. Hoorntje 1, Jan-Henk E. Dambrink 1, Marcel Gosselink 1, Felix Zijlstra 1, and Menko-Jan de Boer 1 on behalf of the On-TIME study group 1 Isala Klinieken, Department of Cardiology, Locatie Weezenlanden, Zwolle, The Netherlands 2 Ambulance Service Region IJsselvecht, The Netherlands 3 Region Noord West Veluwe, The Netherlands KEYWORDS Acute myocardial infarction; Primary angioplasty; Pre-hospital care; Reperfusion Primary coronary angioplasty has been shown to be a very effective reperfusion modality in patients with acute myocardial infarction (MI). However, the time from diagnosis to therapy is often very long, often due to interhospital transfer of the patient. This study evaluates the effect of improving logistics by early infarct diagnosis in the ambulance (ambulance group) and subsequent transportation to a percutaneous coronary intervention (PCI) centre without visiting a nearby non-pci clinic (referred group). Pre-hospital infarct diagnosis and triage in the ambulance (n ¼ 209) were compared with triage at a referral non-pci centre (n ¼ 258) in patients included in the On-TIME (Ongoing Tirofiban In Myocardial infarction Evaluation) study. Baseline characteristics of the two patient groups did not differ significantly, with the exception of a higher prevalence of males in the ambulance group. The ambulance group had a significantly shorter time to treatment (177 vs. 208 min; P, 0.01), a higher initial patency rate (44 vs. 35%; P ¼ 0.045), a better extent of myocardial reperfusion (myocardial blush grade 3: 59 vs. 47%; P ¼ 0.02), a trend toward a higher prevalence of aborted MI (15 vs. 10%; P ¼ 0.08), and a significantly lower rate of death or re-mi at 1 year of follow-up (3 vs. 10%; P ¼ 0.004). It was concluded that early, pre-hospital infarct diagnosis in the ambulance with immediate transportation to the nearest PCI centre is associated with a shorter time to treatment and improved angiographic and clinical outcomes compared with referral from a non-pci centre in patients who are candidates to undergo primary angioplasty for acute MI. Introduction Primary coronary angioplasty has been shown to be a very effective reperfusion modality in patients with acute * Corresponding author. Tel: þ ; fax: þ address: v.r.c.derks@isala.nl myocardial infarction (MI), 1,2 even when additional transport is necessary to a percutaneous coronary intervention (PCI) centre. 3 The decision that a patient is a candidate for transportation to a PCI centre, together with the arrangement of ambulance transport (so called indoor outdoor time), often takes considerable time. In DANAMI 2 (Danish Trial in Acute MI-2), it took a median & The European Society of Cardiology All rights reserved. For Permissions, please journals.permissions@oxfordjournals.org
2 Early triage in acute myocardial infarction K37 of 45 min to decide and arrange referral to the PCI centre, despite the ideal logistic in which the presenting ambulance waited for the decision to transfer. 4 This extra delay might be prevented by pre-hospital infarct diagnosis and triage, in which patients who are candidates for primary angioplasty are immediately transported to the PCI centre. This study compares pre-hospital infarct diagnosis and triage in the ambulance with triage at a referral non-pci centre in patients included in the On-TIME (Ongoing Tirofiban In Myocardial Infarction Evaluation) study a multicentre, placebo-controlled, randomized trial to address the issue of early initiation of tirofiban in patients transferred to undergo primary coronary angioplasty. Forty-one per cent of patients included in On-TIME was randomized in the ambulance after computerized infarct diagnosis. Methods The design, inclusion criteria, and exclusion criteria of the On-TIME study have been described previously. 5 In brief, patients were eligible if they had chest pain for.30 min, together with.0.2 mv (anterior MI) or 0.1 mv (non-anterior MI) of ST-elevation in two contiguous echocardiogram (ECG) leads. Primary angioplasty could be performed within 6 h of the start of symptoms. Patients aged.80, women aged,50, patients who were treated with thrombolytic therapy in the previous 24 h, those receiving warfarin or acenocoumarol within the last 7 days, and those with a contraindication to glycoprotein (GP) IIb/IIIa blockade were excluded. Patients with severe heart failure or cardiogenic shock (Killip class III or IV), and patients who were on haemodialysis were also excluded. The protocol was approved by each institution s Review Board or Ethical Committee. Before transportation, oral informed consent was obtained from all patients by either a physician or a specialized ambulance nurse. The day after the angioplasty procedure, written informed consent was requested. Patients were randomized to either early (before transportation) or late (in the catheterization laboratory) initiation of tirofiban. Emergency transportation was performed after preinformation of arrival of the patient at the catheterization laboratory. Enrolling PCI centres were experienced interventional cardiology centres. Recruitment and randomization in the ambulance were initiated only after a period of training in prehospital infarct diagnosis and care for at least 6 months. Computer diagnosis in the ambulance was made on the basis of a fixed algorithm, which has been described previously. 6,7 Time to diagnosis was defined as the time from symptom onset to infarct diagnosis (first ECG); transportation delay was defined as the time from randomization to arrival at the PCI centre; and total ischaemic time was defined as the time from symptom onset to first balloon inflation. All angiographic and electrocardiographic parameters were analysed by an independent core laboratory (Diagram Zwolle, The Netherlands) and scored by one observer who was unaware of randomization or outcome data. Cumulative ST-segment deviation was defined as the sum of ST-elevation and depression from all 12 ECG leads, as measured 60 ms after the J-point. ST-segment elevation resolution was calculated as described previously. 8 Before transportation, all patients received 500 mg of aspirin and 5000 IU of unfractionated heparin intravenously. Post-PCI, all patients were treated with clopidogrel (300 mg loading dose followed by 75 mg daily for 1 month), aspirin, betablockade, statin therapy, and angiotensin-converting enzyme inhibition. Follow-up was assessed via a planned 30-day visit at the outpatient department and a planned telephonic interview at 1 year. Total death from all causes was recorded. Aborted MI was defined as prolonged chest pain with typical evolutionary ECG changes, coupled with an unstable coronary lesion on the angiogram but without a rise in creatine kinase (CK) of.3 times the upper limit of normal (ULN). Recurrent MI was defined as a new increase in the CK-myocardial bound fraction of more than three times ULN, whether accompanied by chest pain and/or ECG changes, and present in two separate blood samples. Statistical analysis Statistical analysis was performed with the SPSS 10.0 statistical package. All non-continuous angiographic variables were analysed using the x 2 test or Fisher s exact test. Continuous variables were analysed using the analysis of variance or Mann Whitney U test (time variables). Risk stratification was based on the previously described thrombolysis in MI (TIMI) risk criteria. 9 Because of the small number of patients with myocardial blush grade (MBG) 3 pre-pci, the combined incidence of MBG 2 and 3 was reported. Results In the On-TIME study, 40 patients (8%) were randomized at an emergency room of one of the PCI centres, 258 patients (51%) were transported from referral hospitals (referred group), and 209 patients (41%) were diagnosed in the ambulance (ambulance group). The latter two groups form the basis of this report. Baseline characteristics did not differ significantly between the groups with the exception of a greater proportion of males in the ambulance group (Table 1 ). Total ischaemic time was significantly shorter in patients recruited in the ambulance. The percentage of patients who underwent balloon inflation within 2 h of the onset of symptoms was significantly higher in patients after triage in the ambulance (Table 2 ). Patients recruited in the ambulance more often had a patent (TIMI 2 or 3 flow) infarct-related vessel at initial angiography and a higher rate of coronary bypass grafting as initial reperfusion modality. Angiographic and clinical outcomes are described in Table 3. The rate of TIMI 3 flow after PCI did not differ between the two groups, but the percentage of patients with MBG 3 was significantly higher in patients recruited in the ambulance than those in the referred group (59 vs. 47%; P ¼ 0.02). Aborted MI was present in 15% of the ambulance group and in 10% of the referred group (P ¼ 0.08). The combination of death/recurrent MI or stroke at 30 days of follow-up occurred in 4.0% of the referred group, when compared with 2.0% of the ambulance group. At 1 year of follow-up, death or recurrent MI occurred in 10.4% of referred patients vs. 3.4% of patients recruited in the ambulance (P ¼ 0.004). Table 4 shows the effect of
3 K38 Arnoud W.J. van t Hof et al. Table 1 Characteristics and treatment of patients included in the study Baseline Referred group (n ¼ 258) Ambulance group (n ¼ 209) Age (years + SD) Male gender (%) 77 (198/258) 85 (177/209) Diabetes (%) 9 (22/257) 13 (26/208) Hypertension (%) 29 (75/257) 26 (53/208) Smoking a (%) 66 (165/251) 64 (131/205) Anterior MI (%) 46 (115/251) 46 (90/194) Previous MI (%) 10 (25/256) 7 (14/208) Previous CABG (%) 1.6 (4/257) 2.4 (5/208) Previous PCI (%) 4.3 (11/257) 5.8 (12/208) Killip class.1 b (%) 16 (36/233) 19 (35/188) TIMI risk score.3 (%) 42 (108/258) 46 (96/209) Electrocardiographic Cumulative ST-elevation (mm + SD) Cumulative ST-deviation (mm + SD) Angiographic Multivessel disease c (%) 59 (133/226) 51 (101/198) Pre-PCI TIMI 2,3 d (%) 35 (88/253) 44 (86/195) Treatment PCI (%) 90 (228/254) 87 (179/206) CABG (%) 1.6 (4/254) 5.3 (11/206) Other (%) 8.7 (22/254) 7.8 (16/206) CABG, coronary artery bypass grafting; LM, left main. a Current or previous smoking. b Defined as systolic blood pressure,100 mmhg or heart rate.100 beats per min. c Two- or three-vessel disease or LM disease. d TIMI risk score as described by Morrow et al. 9 Table 2 Time delays Referred group Ambulance group Time to diagnosis a 105 (62 149) 75 (48 131) Time to randomization 23 (15 32) 28 (23 34) NS Transportation delay 45 (38 56) 20 (15 26),0.001 Ischaemic time b 208 ( ) 177 ( ),0.001 Percentage treated within 2 h of symptom onset 7% (16/232) 23% (47/203),0.001 Median in minutes (25 75 percentiles). a Time from symptom onset to infarct diagnosis (first electrocardiogram). b Time from symptom onset to first balloon inflation. early initiation of tirofiban in the two different groups. In patients recruited in the ambulance, a significantly higher initial patency was found in patients pre-treated with tirofiban. The effect on thrombus reduction was also most evident in patients who received tirofiban early in the ambulance. Discussion This study showed that patients in whom infarct diagnosis and triage are made in the ambulance and who are immediately transferred to the PCI centre have a shorter time to treatment and a more favourable outcome than patients who are triaged and referred from a non-pci centre. It shows that further streamlining of logistics, in which an unnecessary visit to a non-pci centre is prevented, saves time and may lead to improved patient outcome. The results show that, in particular, presentation delay is shorter in patients who are diagnosed in the ambulance. Of the ambulance patients, 23% underwent angioplasty within 2 h of the onset of symptoms compared with only 7% of patients who were referred from other centres (P, 0.001). In addition, the ambulance group showed a higher initial patency. This shorter time to treatment, together with a higher initial recanalization rate, is probably the reason for the higher number of patients with an aborted MI in the ambulance group.
4 Early triage in acute myocardial infarction K39 Table 3 Aborted infarction, angiographic, electrocardiographic, and clinical outcomes Referred group Ambulance group Aborted MI a (%) 10 (24/246) 15 (31/204) 0.08 Angiographic outcome post-pci TIMI 3 (%) 91 (209/230) 91 (161/177) MBG 3 (%) 47 (106/225) 59 (104/177) Clinical outcome at 30 days Death (%) Re-MI (%) Death/re-MI (%) Clinical outcome at 1 year Death (%) Re-MI (%) Death/re-MI (%) a Defined as prolonged chest pain with typical evolutionary electrocardiographic changes, coupled with an unstable coronary lesion on the angiogram but without a rise in creatine kinase of more than three times the upper limit of normal. Table 4 Effects of early (pre-transportation) or late (catheterization laboratory) administration of tirofiban. Initial patency Early (n ¼ 130) Late (n ¼ 128) Referred group Pre-PCI (%) TIMI 2,3 (%) 36 (47/129) 33 (41/124) 0.57 MBG 2,3 (%) 27 (34/128) 22 (27/122) 0.42 Post-PCI TIMI 3 (%) 88 (102/116) 94 (107/114) 0.12 Early (n ¼ 103) Late (n ¼ 106) Ambulance group (n ¼ 103) (n ¼ 106) Pre-PCI TIMI 2,3 (%) 52 (50/97) 37 (36/98) 0.04 MBG 2,3 (%) 36 (33/92) 22 (21/97) 0.03 Post-PCI TIMI 3 (%) 92 (78/85) 90 (83/92) 0.72 The finding that patients diagnosed and triaged in the ambulance have a higher initial patency than those transferred from a non-pci centre was also reported in a previous study. 7 The very early administration of aspirin and heparin might be the reason for the higher recanalization rate in these patients. From Table 4, it is also clear that the early administration of tirofiban is more effective in patients recruited in the ambulance, possibly because the occlusive thrombus is less organized when the patient is treated early after the onset of symptoms. In thrombolytic trials, the concept of increased effectivity with shorter duration of symptoms is well recognized and is known as the golden hour ; this concept might explain the better outcome seen in patients treated with pre-hospital thrombolysis than in those given thrombolysis in hospital. 10 Myocardial reperfusion With regard to epicardial reperfusion, no difference in post-pci TIMI 3 flow was seen between the two groups. However, the rate of normalized myocardial blush (MBG 3) was significantly higher in the ambulance group than in the referred group, suggesting that, in particular, myocardial reperfusion was better in this group of patients. This is probably due to the shorter time to treatment in this group, as previous studies have shown that ischaemic time is an independent predictor of the extent of myocardial reperfusion. 11,12 Clinical implications The most recent version of the American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the treatment of patients with STelevation acute MI (STEMI) state that a pre-hospital 12- lead ECG should be made by Advanced Cardiac Life Support providers in all patients suspected of STEMI (class IIa, level of evidence B) and that all patients with a high risk of dying should immediately be transferred to the PCI centre (class IIa, level of evidence B). 13 The study reported here shows that the implementation of these guidelines might further improve outcome, merely by reducing time to treatment, especially in those patients at high risk of adverse events. These high-risk patients, in particular, might benefit from a further reduction in time to treatment. 14 Limitations This study is not a randomized comparison between triage in the ambulance and triage at a referral centre. It would no longer be ethical to conduct such a trial as this would mean that treatment delay would deliberately be increased in one arm. In the ambulance group, total ischaemic time was significantly shorter than in the referred group, but the shorter transportation time in this group could have been a contributory factor.
5 K40 Arnoud W.J. van t Hof et al. Referred patients travelled a median of 41 km to the PCI centre, whereas ambulance patients were transported a median of 24 km. It is difficult to differentiate which part of this reduced transportation distance is due to improved logistics and which is due to a possible shorter distance to the PCI centre. Conclusions In patients who are candidates for primary angioplasty for acute MI, pre-hospital infarct diagnosis and triage is associated with shorter time to treatment, a higher initial patency, and better angiographic and clinical outcomes after PCI compared with triage and referral from a non-pci centre. All efforts should, therefore, be made to implement pre-hospital infarct diagnosis, triage, and therapy in the care of patients with an acute MI. Acknowledgement This study was supported by an unrestricted grant from Merck & Co., USA. We wish to thank all ambulance personnel for their contribution to this study. Conflict of interest: The On-TIME trial was supported by an unrestricted grant from Merck & Co., USA. Dr van t Hof has received speaker fees for various presentations about the results of the trial. Appendix I Members of the On-TIME study group Steering Committee: M.J. de Boer, E. Boersma, A.J. van Boven, R. Buirma (non-voting member), J. Dille, A.W.J. van t Hof, R.J. de Winter. Ambulance Coordinators: F. Hollak (Ambulance Dienst Regio IJssel Vecht), F. de Pooter (Ambulance Dienst Regio Noord West Veluwe). Referral Centre Coordinators: T. Bouwmeester (Winschoten), R. Brons (Meppel), R. Dijkgraaf (Harderwijk), W. Jap (Apeldoorn), M.J. de Leeuw (Assen), A. Mosterd (Amersfoort), C. Oei (Heerenveen), J. Saelman (Hoogeveen). PCI Centre Coordinators: The Netherlands: J.M. ten Berg (Nieuwegein), A.J. van Boven (Groningen), J.H.E. Dambrink (Zwolle), R.J. de Winter (Amsterdam); Italy: S. Petronio (Pisa). References 1. Zijlstra F, Hoorntje JCA, de Boer MJ et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341: Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361: Dalby M, Bouzamondo A, Lechat P et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003;108: Andersen HR, Nielsen TT, Rasmussen K et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349: van t Hof AW, Ernst N, de Boer MJ et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J 2004;25: Grijseels EW, Bouten MJ, Lenderink T et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur Heart J 1995;16: Ernst NMSKJ, de Boer MJ, van t Hof AWJ et al. Pre-hospital triage for angiography-guided therapy for acute myocardial infarction. Netherlands Heart J 2004;12: van t Hof AW, Liem A, de Boer MJ et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 1997;350: Morrow DA, Antman EM, Charlesworth A et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102: Boersma E, Akkerhuis M, Simoons ML. Primary angioplasty versus thrombolysis for acute myocardial infarction. N Engl J Med 2000;342: van t Hof AW, Liem A, Suryapranata H et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97: De Luca G, van t Hof AW, de Boer MJ et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J 2004;25: ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 Guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44: De Luca G, Ernst N, Zijlstra F et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2004;43:
Preprocedural TIMI Flow and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty
Journal of the American College of Cardiology Vol. 43, No. 8, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.042
More informationPrimary PCI versus thrombolytic therapy: long-term follow-up according to infarct location
Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction
More informationJournal of the American College of Cardiology Vol. 39, No. 11, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 39, No. 11, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01856-9
More informationInfluence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
629 Influence of Treatment Delay on Infarct Size and Clinical Outcome in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty AYLEE L. LIEM, MD, ARNOUD W.J. VAN T HOF, MD, JAN C.A.
More informationSymptom-Onset-to-Balloon Time and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty
Journal of the American College of Cardiology Vol. 42, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00919-7
More informationAntiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria
University of Groningen Antiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria IMPORTANT NOTE: You are advised to consult the publisher's
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationKeywords Non ST-segment elevation ACS Antithrombotic therapy Glycoprotein IIb/IIIa inhibitor Tirofiban. Introduction
J Thromb Thrombolysis (2007) 24:241 246 DOI 10.1007/s19-007-0015-y Routine upstream versus selective down stream use of tirofiban in non-st elevation myocardial infarction patients scheduled for early
More informationJournal of the American College of Cardiology Vol. 44, No. 6, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, No. 6, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.050
More informationThe Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium
The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications
More informationDespite the excellent results of reperfusion therapies for
Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty Implications for Early Discharge Giuseppe De Luca, MD; Harry Suryapranata, MD, PhD; Arnoud W.J. van t
More informationChapter 3. Departments of a Cardiology and b Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands; c
Chapter 3 Incidence, patient s characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment
More informationCurrent Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach
Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants
More informationA. W. J. van t Hof, A. Liem, H. Suryapranata, J. C. A. Hoorntje, M.-J de Boer and F. Zijlstra
European Heart Journal (1998) 19, 118 123 Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction
More informationUniversity of Groningen
University of Groningen Computer assisted decision support in acutely ill patients. Application in glucose management and quantification of myocardial reperfusion Vogelzang, Mathijs IMPORTANT NOTE: You
More informationFacilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?
Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at
More informationThe treatment of myocardial infarction
Heart 2001;85:705 709 CORONARY DISEASE Acute myocardial infarction: primary angioplasty Felix Zijlstra Department of Cardiology, Hospital De Weezenlanden, Zwolle, The Netherlands Correspondence to: Dr
More informationA Report From the Second National Registry of Myocardial Infarction (NRMI-2)
1240 JACC Vol. 31, No. 6 Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial
More informationPRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE
PRIMARY CORONARY ANGIOPLASTY VERSUS INTRAVENOUS THROMBOLYSIS FOR ACUTE MYOCARDIAL INFARCTION - A COMPARATIVE STUDY AT QUEEN ALIA HEART INSTITUTE Walid Sawalha MD, MBBS (Lond), MRCP(UK)* ABSTRACT Objectives:
More informationProximal embolic protection and biomarkers of reperfusion in ST-segment elevation myocardial infarction Haeck, J.D.E.
UvA-DARE (Digital Academic Repository) Proximal embolic protection and biomarkers of reperfusion in ST-segment elevation myocardial infarction Haeck, J.D.E. Link to publication Citation for published version
More informationPatient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough
Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis
More informationThe influence of residential distance on time to treatment in ST-elevation myocardial infarction patients
Neth Heart J (2014) 22:513 519 DOI 10.1007/s12471-014-0599-8 ORIGINAL ARTICLE The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients S. Postma & J. H.
More informationAt the most severe end of the spectrum of acute coronary syndromes is ST-segment
Focused Issue of This Month Reperfusion Strategies in Acute ST-segment Elevation Myocardial Infarction Young-Jo Kim, MD Division of Cardiology, Department of Internal Medicine, Yeungnam University College
More informationCritics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS
Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner
More informationST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): DECREASING THE TIME TO TREATMENT IN THE ED W. Brian Gibler, MD Professor and Chairman; Department of Emergency Medicine, University of Cincinnati College
More informationLong-Term Prognostic Value of ST-Segment Resolution in Patients Treated With Fibrinolysis or Primary Percutaneous Coronary Intervention
Journal of the American College of Cardiology Vol. 54, No. 19, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.03.084
More informationAn Open Randomized Study Prague-5 ˆ
Next Day Discharge After Successful Primary Angioplasty for Acute ST Elevation Myocardial Infarction An Open Randomized Study Prague-5 Radovan JIRMÁR, 1 MD, Petr WIDIMSKÝ, 1 MD, Jan CAPEK, 1 MD, Ota HLINOMAZ,
More informationMyocardial Infarction In Dr.Yahya Kiwan
Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting
More informationAnnie Chou Internal Medicine PGY3 University of British Columbia. Rocky Mountain Internal Medicine Conference November 24, 2011
Annie Chou Internal Medicine PGY3 University of British Columbia Rocky Mountain Internal Medicine Conference November 24, 2011 Role of the ECG in STEMI Diagnosis of myocardial infarction Localization of
More informationClinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective
Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical
More informationPharmaco-Invasive Approach for STEMI
Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),
More informationPrognostic implications of myocardial injury around percutaneous coronary interventions Nienhuis, Marcus Bernardus
University of Groningen Prognostic implications of myocardial injury around percutaneous coronary interventions Nienhuis, Marcus Bernardus IMPORTANT NOTE: You are advised to consult the publisher's version
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Antiplatelet Section of the Guidelines) Authors: Dr. M. Love, Dr. I. Bata, K. Harrigan
More informationThrombolysis in Acute Myocardial Infarction
CHAPTER 70 Thrombolysis in Acute Myocardial Infarction J. S. Hiremath Introduction Reperfusion of the occluded coronary artery at the earliest is the most important aim of management of STEMI. Once a flow
More informationFrans Van de Werf, MD, PhD Leuven, Belgium
STEMI Cases and the ESC STEMI Guidelines Frans Van de Werf, MD, PhD Leuven, Belgium The Easy Case 2/21/2011 History and Risk Factors 50-year old male patient Past medical history: Teratoma right testis
More informationREFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO
REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients
More informationSHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?
SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationHigh-sensitive troponin. Introduction. Platelet aggregation inhibition at admission
Neth Heart J (2017) 25:181 185 DOI 10.1007/s12471-016-0939-y GUIDELINES 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:
More informationImpact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.
Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationManagement of Acute Myocardial Infarction
Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care
More informationControversies on Primary angioplasty in STEMI
Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical
More informationAbortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients characteristics, and prognosis
496 CARDIOVASCULAR MEDICINE Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients characteristics, and prognosis E J P Lamfers, T E H Hooghoudt, D P Hertzberger,
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationAcute Coronary Syndrome (ACS) is the consequence of
Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok
More informationCLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA
RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research
More informationImproving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark
Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The
More informationImproving the Outcomes of
Improving the Outcomes of STEMI Shelley Valaire, ACP; and Robert Welsh, MD, FRCPC Presented at the University of Alberta s 6th Annual Cardiology Update for General Practitioners and Internists, Edmonton,
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationDISCUSSION QUESTION - 1
CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure
More informationPre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction
European Heart Journal (2005) 26, 2063 2074 doi:10.1093/eurheartj/ehi413 Special article Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationJournal of the American College of Cardiology Vol. 43, No. 4, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.08.055
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI
Heart Mirror Journal From Affiliated Egyptian Universities and Cardiology Centers Vol. 6, No. 3, 2012 ISSN 1687-6652 ORIGINAL ARTICLE for Failed Fibrinolysis in Patients with STEMI Mohamed Salem, MD, PhD;
More informationThis House believes that experience and size is not relevant
This House believes that experience and size is not relevant Providing a primary angioplasty service Hotly debated topics Treatment of MI Stewed prunes vs warmed milk Treatment of MI early mobilisation
More informationAntiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria
University of Groningen Antiplatelet therapy in myocardial infarction and coronary stent thrombosis Heestermans, Antonius Adrianus Cornelius Maria IMPORTANT NOTE: You are advised to consult the publisher's
More informationThrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam
Seoul, 27 April TCT AP 2010 Thrombus Aspiration before PCI: Routine Mandatory Robbert J de Winter MD PhD FESC Professor Clinical Cardiology Academic Medical Center University of Amsterdam AMC Amsterdam
More informationArticles. Methods Study design and patients The Ongoing Tirofiban in Myocardial Evaluation (On-TIME) 2 trial was a prospective, multicentre, placebo-
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Arnoud W J van
More informationImproved Survival Associated With Pre-Hospital Triage Strategy in a Large Regional ST-Segment Elevation Myocardial Infarction Program
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 12, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcin.2012.07.013
More informationIntraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention
Journal of the American College of Cardiology Vol. 57, No. 19, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.061
More informationRisk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium
Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from
More informationPPCI in STEMI. ESC at the 22nd Annual Conference of the Saudi Heart Association February 21th, 2011
PPCI in STEMI Dr Hassan Mhish Interventional Cardiology Consultant Cardiology Fellowship Program Director Prince Salman Heart Center King Fahd Medical City Riyadh, KSA ESC at the 22nd Annual Conference
More informationAcute Coronary Syndrome
Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with
More informationMode of admission and its effect on quality indicators in Belgian STEMI patients
2015 Mode of admission and its effect on quality indicators in Belgian STEMI patients Prof dr M Claeys National Coordinator STEMI registry 29-6-2015 Background The current guidelines for the management
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationTrial Update- TOTAL. Jonathan Byrne
Trial Update- TOTAL Jonathan Byrne No conflicts of interest Background- rationale for thrombectomy Major Limitation of primary PCI: distal embolisation and reduced flow Stonel JACC 2002;39:591-7 Henriques
More informationLong term outcome and cost-evectiveness of stenting versus balloon angioplasty for acute myocardial infarction
Heart 2001;85:667 671 667 Department of Cardiology, Isala Klinieken, Hospital de Weezenlanden, Groot Wezenland 20, 8011 JW Zwolle, Netherlands H Suryapranata J P Ottervanger E Nibbering AWJvan thof J C
More informationLiterature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction
Literature Review and Recommendations Prehospital Fibrinolytics Administration for Acute Myocardial Infarction EMS Bureau Protocol Review Steering Committee Background In 2009, approximately 683,000 Americans
More informationCardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008.
Cardiovascular Health Nova Scotia Update to Antiplatelet Sections of the Nova Scotia Guidelines for Acute Coronary Syndromes, 2008. ST Elevation Myocardial Infarction (STEMI)-Acute Coronary Syndrome Guidelines:
More informationUtilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology Vol. 53, No. 2, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.030
More informationThe First 12 Hours. ST-Segment Elevation AMI: Introduction. Definitions
ST-Segment Elevation AMI: The First 12 Hours Acute myocardial infarction (AMI) accounts for half of the deaths due to ischemic heart disease and is associated with significant use of resources. Because
More informationJournal of the American College of Cardiology Vol. 33, No. 3, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 3, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00644-5 Primary
More informationFacilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients?
Editorial Comment Acta Cardiol Sin 2014;30:292 297 Facilitated Percutaneous Coronary Intervention in STEMI Patients: Does It Work in Asian Patients? Wei-Chun Huang, 1,2,3 Cheng-Hung Chiang 1,2 and Chun-Peng
More informationPrimary Angioplasty for the Treatment of Acute ST- Segment Elevated Myocardial Infarction
Ontario Health Technology Assessment Series 2004; Vol. 4, No. 10 Primary Angioplasty for the Treatment of Acute ST- Segment Elevated Myocardial Infarction An Evidence-Based Analysis August 2004 Medical
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationShould All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?
Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure
More informationPercutaneous Coronary Interventions Without On-site Cardiac Surgery
Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European
More informationA Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction Michel R. Le May, M.D., Derek Y. So, M.D., Richard
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationOUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION
OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,
More informationManagement of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police
Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis
More informationEffect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden
More informationThe PAIN Pathway for the Management of Acute Coronary Syndrome
2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina
More informationTHE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION
: 616.127-005.8 -..,.. -...,, ( ), 2011, 581 182. 195 592 ( ) 385 590 -. 4,3 % 8,8 % ( ). 2011 62 329,, 24 931 (40 %) -. : - - ; ; 70 % ST ( ST); ST - 24. : ST,. THE CURRENT SITUATION AND FUTURE OF THE
More informationUpdated and Guideline Based Treatment of Patients with STEMI
Updated and Guideline Based Treatment of Patients with STEMI Eli I. Lev, MD Director, Cardiac Catheterization Laboratory Hasharon Hospital, Rabin Medical Center Associate Professor of Cardiology Tel-Aviv
More informationSustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction
Journal of the American College of Cardiology Vol. 46, No. 1, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.047
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationAcute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine
Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute
More informationThrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology
Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology UNIVERSITY OF AARHUS 1 COI Speakers fee: Aspen, AZ, Bayer, BMS/Pfizer Departmental research grant:
More informationJournal of the American College of Cardiology Vol. 45, No. 4, by the American College of Cardiology Foundation ISSN /05/$30.
Journal of the American College of Cardiology Vol. 45, No. 4, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.031
More informationRecurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy
Case Report Acta Cardiol Sin 2013;29:462 466 Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy Hung-Hao Lee, 1 Tsung-Hsien
More informationThe Strategic Reperfusion Early After STEMI study Implications for clinical practice
The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional
More informationEarlier reperfusion in patients with ST-elevation Myocardial infarction by use of helicopter
Knudsen et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:70 ORIGINAL RESEARCH Open Access Earlier reperfusion in patients with ST-elevation Myocardial infarction by
More informationPaclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention
original article Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention Gerrit J. Laarman, M.D., Ph.D., Maarten J. Suttorp, M.D., Ph.D., Maurits T. Dirksen, M.D., Loek
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationAcute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand
main/0202_new 02/03/06 Acute myocardial infarction Search date August 2004 Nicholas Danchin and Eric Durand QUESTIONS Which treatments improve outcomes in acute myocardial infarction?...4 Which treatments
More informationAcute Coronary Syndromes
Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management
More information